{"organizations": [], "uuid": "09d2f2797e8ed9f40aa8c13567265148441cc3f0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/legal", "section_title": "Legal News | Reuters", "url": "https://www.reuters.com/article/health-flonase/gsk-loses-bid-to-overturn-ruling-allowing-louisianas-flonase-case-idUSL2N1PX2HB", "country": "US", "domain_rank": 408, "title": "GSK loses bid to overturn ruling allowing Louisiana's Flonase case", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-08T07:03:00.000+02:00", "replies_count": 0, "uuid": "09d2f2797e8ed9f40aa8c13567265148441cc3f0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/health-flonase/gsk-loses-bid-to-overturn-ruling-allowing-louisianas-flonase-case-idUSL2N1PX2HB", "ord_in_thread": 0, "title": "GSK loses bid to overturn ruling allowing Louisiana's Flonase case", "locations": [], "entities": {"persons": [], "locations": [{"name": "louisiana", "sentiment": "none"}, {"name": "philadelphia", "sentiment": "none"}], "organizations": [{"name": "gsk", "sentiment": "negative"}, {"name": "westlaw", "sentiment": "none"}, {"name": "glaxosmithkline", "sentiment": "none"}, {"name": "3rd u.s. circuit court of appeal", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "A federal appeals court on Wednesday said it will not reconsider a decision to allow the state of Louisiana to bring antitrust claims against GlaxoSmithKline, even though it did not opt out of a related, previous class action settlement.\nThe 3rd U.S. Circuit Court of Appeal in Philadelphia rejected GSK’s bid to have the full court to review a decision holding Louisiana’s sovereign immunity meant it was not bound by a deal resolving claims the drugmaker tried to delay generic versions of its allergy spray Flonase.\nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2E7Gzhv\n ", "external_links": ["http://bit.ly/2E7Gzhv", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T07:03:00.000+02:00", "crawled": "2018-02-08T15:05:46.003+02:00", "highlightTitle": ""}